They Were Told to"Just Manage It"Here's What Happened Instead.

No. Nutcracker syndrome is not always the root cause of POTS. POTS names a pattern; the investigation still has to look at the vascular system, kidneys, adrenals, vagus nerve and wider neurological picture. In this case, imaging showed Nutcracker syndrome and labs showed antiphospholipid syndrome. Those findings mattered. Pain, blood-pressure changes and headaches alone do not tell us whether someone has a clot.

Mold can be part of the problem without being the most foundational problem. The question is whether exposure is still happening, what else is affecting the person, and whether the sequence makes sense. Taking binders without knowing the big picture can make you sick. A.H.’s review changed the aggressive binder protocol she had self-started: drainage came first for three weeks. Her recorded urinary ochratoxin A changed from 18.4 to 2.1 ng/g over an 11-month case timeline. Antibiotic history belongs in that investigation; it is not, by itself, proof of environmental mold illness.

Testosterone can make you feel better. That does not automatically answer why it was low or why treatment stalled. In R.T.’s case, the investigation focused on the office exposure, mycotoxin findings and a second burden that changed the treatment order. Over nine months, the recorded total testosterone changed from 241 to 612 ng/dL and urinary trichothecene from 0.42 to less than 0.07 ppb. The documented outcome was recovery of endogenous testosterone and stopping TRT. Those results describe this case; they do not establish that testosterone mobilizes mercury.

Surgery can remove a blockage. If the reason it happened in the first place is not addressed, it can come back. D.L.’s investigation included sinus culture, urine mycotoxin testing and the wider gut and inflammatory picture—not just another look at the obstruction. The recorded aflatoxin changed from 3.9 to 0.4 ppb and hs-CRP from 8.2 to 1.1 mg/L. The 14-month case records no sinus infection in the preceding 12 months. The sinuses and gut both have mucosal barriers, but they are not anatomically the same tissue.

No. Blood thinners serve their purpose. The clinical question is also what is driving the clotting and whether a more complex issue needs investigation. In the documented antiphospholipid case, follow-up clotting markers changed over a three-month protocol and anticoagulant therapy was discontinued under physician supervision. That is not an instruction for anyone else to stop medication. Medication changes belong with the prescribing physician.

The imaging timeline is the answer. Cysts were identified in utero. The recorded largest cyst changed from 21 × 19 × 16 mm to 8 × 10 × 8 mm during a seven-month protocol, with reductions in the other measured cysts. The existing case record reports complete resolution by 2025. Dr. Nicole’s investigation connected the kidney picture with liver health and what was affecting the child as a whole. The imaging documents the change; it does not show that these cysts formed to contain toxins or pathogens.